|Have Questions?||Leave a Message or Start an on-line Chat|
Unlock the potential of our Recombinant Human TNFRSF10B protein in cancer research and explore its role as a tumor necrosis factor receptor superfamily member 10B. Also known as death receptor 5 (DR5), TRAIL receptor 2 (TRAIL-R2), or CD262, TNFRSF10B plays a crucial role in apoptotic signaling pathways and is involved in the regulation of cell death in various cancer types. By studying TNFRSF10B, you can gain valuable insights into tumor biology and potentially develop novel therapeutic approaches.
Our Tag-Free recombinant protein is produced using the precise E. coli expression system, ensuring high purity (>97% as determined by SDS-PAGE and HPLC) and minimal endotoxin contamination (<1.0 EU/µg). The protein covers amino acids 52 to 183, representing a partial length of the TNFRSF10B sequence. This preserves its native structure, allowing for reliable and consistent results in your experiments.
Experience the full biological activity of TNFRSF10B with our recombinant protein, as it demonstrates its functionality by reducing the production of TNF induced by lipopolysaccharide (LPS) in fresh human peripheral blood mononuclear cells (PBMC). This activity indicates its ability to neutralize endogenous TRAIL. The lyophilized powder form ensures excellent stability and easy reconstitution for use in various experimental applications. Uncover the intricate mechanisms underlying cancer progression and apoptotic signaling with our high-quality TNFRSF10B protein.
There are currently no reviews for this product.